190 related articles for article (PubMed ID: 36710413)
1. Association between F-box-only protein 43 overexpression and hepatocellular carcinoma pathogenesis and prognosis.
Wu S; Qin L; Yang J; Wang J; Shen Y
Cancer Med; 2023 Apr; 12(8):10062-10076. PubMed ID: 36710413
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of FBXO43 in hepatocellular carcinoma and its impact on tumor cell proliferation, migration and invasion.
Ma R; Liu W; Sun T; Dang C; Li K
PeerJ; 2023; 11():e15373. PubMed ID: 37250703
[TBL] [Abstract][Full Text] [Related]
3. A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F in Hepatocellular Carcinoma.
Gao D; Li S; Guo H; Liu X; Liu Z; Li L; Bao L; Dang X
Front Biosci (Landmark Ed); 2024 May; 29(5):202. PubMed ID: 38812312
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of long non-coding RNA
Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
[No Abstract] [Full Text] [Related]
5. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
6. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
7. Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma.
Lin Y; He Z; Gao X; Lu L; Lu C; Huang J; Luo M; Ye J; Liang R
Oxid Med Cell Longev; 2022; 2022():8284500. PubMed ID: 36211823
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
9. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
[TBL] [Abstract][Full Text] [Related]
10. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
[TBL] [Abstract][Full Text] [Related]
11. LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients.
Ma Y; Sun WL; Ma SS; Zhao G; Liu Z; Lu Z; Zhang D
BMC Bioinformatics; 2023 Feb; 24(1):54. PubMed ID: 36803542
[TBL] [Abstract][Full Text] [Related]
12. FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma.
Wang F; Qiao Y; Yu J; Ren X; Wang J; Ding Y; Zhang X; Ma W; Ding Y; Liang L
PLoS One; 2013; 8(6):e65495. PubMed ID: 23826080
[TBL] [Abstract][Full Text] [Related]
13. Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma.
Mo M; Ma X; Luo Y; Tan C; Liu B; Tang P; Liao Q; Liu S; Yu H; Huang D; Zeng X; Qiu X
BMC Cancer; 2022 Oct; 22(1):1098. PubMed ID: 36289466
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
16. FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration.
Li CM; Zhang J; Wu W; Zhu Z; Li F; Wu D; Wang XJ; Xie CM; Gong JP
Front Oncol; 2023; 13():1138348. PubMed ID: 36937431
[TBL] [Abstract][Full Text] [Related]
17. F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner.
Zhou H; Zeng C; Liu J; Luo H; Huang W
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765911
[TBL] [Abstract][Full Text] [Related]
18. High Expression of F-Box Protein 43 Is Associated With Poor Prognosis and Adjuvant Chemotherapy Resistance in Colorectal Cancer.
Liu J; Yang X; Li M; Liu YY; Wang Y; Li S; Zheng F
World J Oncol; 2023 Aug; 14(4):246-254. PubMed ID: 37560338
[TBL] [Abstract][Full Text] [Related]
19. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
20. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]